{
  "fullName": "Partha Majumder",
  "slug": "partha-majumder",
  "title": "MD",
  "specialty": "Population genetics",
  "subSpecialty": null,
  "geography": {
    "country": "India",
    "region": null,
    "city": null
  },
  "status": "LIVING",
  "tier": "UNRANKED",
  "rankingScore": 28,
  "hIndex": 110,
  "yearsActive": 0,
  "verifiedSurgeries": 0,
  "livesSaved": 0,
  "biography": "Partha Pratim Majumder is a Bangladeshi mime artist who is considered the \"forerunner\" of mime art in Bangladesh. Born in Pabna District in the north-western part of the country, Partha went to France in early 1980s under a scholarship program and trained under Marcel Marceau. Since then he has been performing in several countries throughout the world earning international recognition. In 2010, he was awarded the Ekushey Padak, one of the highest civilian awards in Bangladesh. In 2011, the French government awarded him the Chevalier de l’Ordre des Arts et des Lettres. He is the elder brother of musician Bappa Mazumder and music composer Partha Sharothi Mojumdar.",
  "aiSummary": "Partha Majumder is a population genetics specialist with an H-index of 110 at Genomics (Faculty). Has been published in New England Journal of Medicine, NEJM Evidence, Nature Medicine. Based in India.",
  "techniquesInvented": [],
  "hasInvention": false,
  "portraitUrl": "https://upload.wikimedia.org/wikipedia/commons/thumb/e/e1/Partha_Pratim_Majumder.JPG/330px-Partha_Pratim_Majumder.JPG",
  "galleryUrls": [],
  "npiNumber": null,
  "orcidId": null,
  "medicalSpecialty": [
    "Population genetics"
  ],
  "knowsAbout": [],
  "affiliations": [
    {
      "hospitalName": "Genomics",
      "role": "Faculty",
      "hospitalUrl": "#"
    }
  ],
  "citations": [
    {
      "title": "Revised International Prognostic Scoring System for Myelodysplastic Syndromes",
      "journal": "Blood",
      "year": 2012,
      "citationCount": 3053,
      "doi": "10.1182/blood-2012-03-420489",
      "sourceUrl": "https://doi.org/10.1182/blood-2012-03-420489",
      "verified": true
    },
    {
      "title": "International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data",
      "journal": "Blood",
      "year": 2022,
      "citationCount": 2406,
      "doi": "10.1182/blood.2022015850",
      "sourceUrl": "https://doi.org/10.1182/blood.2022015850",
      "verified": true
    },
    {
      "title": "Somatic Mutations of Calreticulin in Myeloproliferative Neoplasms",
      "journal": "New England Journal of Medicine",
      "year": 2013,
      "citationCount": 1932,
      "doi": "10.1056/nejmoa1311347",
      "sourceUrl": "https://doi.org/10.1056/nejmoa1311347",
      "verified": true
    },
    {
      "title": "Clinical and biological implications of driver mutations in myelodysplastic syndromes",
      "journal": "Blood",
      "year": 2013,
      "citationCount": 1808,
      "doi": "10.1182/blood-2013-08-518886",
      "sourceUrl": "https://doi.org/10.1182/blood-2013-08-518886",
      "verified": true
    },
    {
      "title": "Somatic<i>SF3B1</i>Mutation in Myelodysplasia with Ring Sideroblasts",
      "journal": "New England Journal of Medicine",
      "year": 2011,
      "citationCount": 1202,
      "doi": "10.1056/nejmoa1103283",
      "sourceUrl": "https://doi.org/10.1056/nejmoa1103283",
      "verified": true
    },
    {
      "title": "Time-Dependent Prognostic Scoring System for Predicting Survival and Leukemic Evolution in Myelodysplastic Syndromes",
      "journal": "Journal of Clinical Oncology",
      "year": 2007,
      "citationCount": 1033,
      "doi": "10.1200/jco.2006.08.5696",
      "sourceUrl": "https://doi.org/10.1200/jco.2006.08.5696",
      "verified": true
    },
    {
      "title": "Prognostic Factors and Life Expectancy in Myelodysplastic Syndromes Classified According to WHO Criteria: A Basis for Clinical Decision Making",
      "journal": "Journal of Clinical Oncology",
      "year": 2005,
      "citationCount": 856,
      "doi": "10.1200/jco.2005.01.7038",
      "sourceUrl": "https://doi.org/10.1200/jco.2005.01.7038",
      "verified": true
    },
    {
      "title": "Molecular International Prognostic Scoring System for Myelodysplastic Syndromes",
      "journal": "NEJM Evidence",
      "year": 2022,
      "citationCount": 740,
      "doi": "10.1056/evidoa2200008",
      "sourceUrl": "https://doi.org/10.1056/evidoa2200008",
      "verified": true
    },
    {
      "title": "Diagnosis and treatment of primary myelodysplastic syndromes in adults: recommendations from the European LeukemiaNet",
      "journal": "Blood",
      "year": 2013,
      "citationCount": 662,
      "doi": "10.1182/blood-2013-03-492884",
      "sourceUrl": "https://doi.org/10.1182/blood-2013-03-492884",
      "verified": true
    },
    {
      "title": "Implications of TP53 allelic state for genome stability, clinical presentation and outcomes in myelodysplastic syndromes",
      "journal": "Nature Medicine",
      "year": 2020,
      "citationCount": 601,
      "doi": "10.1038/s41591-020-1008-z",
      "sourceUrl": "https://doi.org/10.1038/s41591-020-1008-z",
      "verified": true
    },
    {
      "title": "Clinical significance of SF3B1 mutations in myelodysplastic syndromes and myelodysplastic/myeloproliferative neoplasms",
      "journal": "Blood",
      "year": 2011,
      "citationCount": 493,
      "doi": "10.1182/blood-2011-09-377275",
      "sourceUrl": "https://doi.org/10.1182/blood-2011-09-377275",
      "verified": true
    },
    {
      "title": "Clinical significance of somatic mutation in unexplained blood cytopenia",
      "journal": "Blood",
      "year": 2017,
      "citationCount": 451,
      "doi": "10.1182/blood-2017-01-763425",
      "sourceUrl": "https://doi.org/10.1182/blood-2017-01-763425",
      "verified": true
    },
    {
      "title": "SF3B1 mutation identifies a distinct subset of myelodysplastic syndrome with ring sideroblasts",
      "journal": "Blood",
      "year": 2015,
      "citationCount": 422,
      "doi": "10.1182/blood-2015-03-633537",
      "sourceUrl": "https://doi.org/10.1182/blood-2015-03-633537",
      "verified": true
    },
    {
      "title": "Allogeneic hematopoietic stem cell transplantation for MDS and CMML: recommendations from an international expert panel",
      "journal": "Blood",
      "year": 2017,
      "citationCount": 368,
      "doi": "10.1182/blood-2016-06-724500",
      "sourceUrl": "https://doi.org/10.1182/blood-2016-06-724500",
      "verified": true
    },
    {
      "title": "The genetic basis of myelodysplasia and its clinical relevance",
      "journal": "Blood",
      "year": 2013,
      "citationCount": 343,
      "doi": "10.1182/blood-2013-09-381665",
      "sourceUrl": "https://doi.org/10.1182/blood-2013-09-381665",
      "verified": true
    },
    {
      "title": "Integrating clinical features and genetic lesions in the risk assessment of patients with chronic myelomonocytic leukemia",
      "journal": "Blood",
      "year": 2016,
      "citationCount": 342,
      "doi": "10.1182/blood-2016-05-714030",
      "sourceUrl": "https://doi.org/10.1182/blood-2016-05-714030",
      "verified": true
    },
    {
      "title": "Myelodysplastic Syndromes — Coping with Ineffective Hematopoiesis",
      "journal": "New England Journal of Medicine",
      "year": 2005,
      "citationCount": 338,
      "doi": "10.1056/nejmp048266",
      "sourceUrl": "https://doi.org/10.1056/nejmp048266",
      "verified": true
    },
    {
      "title": "Myelodysplastic Syndromes Are Propagated by Rare and Distinct Human Cancer Stem Cells In Vivo",
      "journal": "Cancer Cell",
      "year": 2014,
      "citationCount": 318,
      "doi": "10.1016/j.ccr.2014.03.036",
      "sourceUrl": "https://doi.org/10.1016/j.ccr.2014.03.036",
      "verified": true
    },
    {
      "title": "Development and validation of a prognostic scoring system for patients with chronic myelomonocytic leukemia",
      "journal": "Blood",
      "year": 2013,
      "citationCount": 311,
      "doi": "10.1182/blood-2012-08-452938",
      "sourceUrl": "https://doi.org/10.1182/blood-2012-08-452938",
      "verified": true
    },
    {
      "title": "Erythropoietin and Granulocyte-Colony Stimulating Factor Treatment Associated With Improved Survival in Myelodysplastic Syndrome",
      "journal": "Journal of Clinical Oncology",
      "year": 2008,
      "citationCount": 296,
      "doi": "10.1200/jco.2007.15.4906",
      "sourceUrl": "https://doi.org/10.1200/jco.2007.15.4906",
      "verified": true
    },
    {
      "title": "Deregulated gene expression pathways in myelodysplastic syndrome hematopoietic stem cells",
      "journal": "Leukemia",
      "year": 2010,
      "citationCount": 286,
      "doi": "10.1038/leu.2010.31",
      "sourceUrl": "https://doi.org/10.1038/leu.2010.31",
      "verified": true
    },
    {
      "title": "<i>SF3B1</i>-mutant MDS as a distinct disease subtype: a proposal from the International Working Group for the Prognosis of MDS",
      "journal": "Blood",
      "year": 2020,
      "citationCount": 285,
      "doi": "10.1182/blood.2020004850",
      "sourceUrl": "https://doi.org/10.1182/blood.2020004850",
      "verified": true
    },
    {
      "title": "Role of Reduced-Intensity Conditioning Allogeneic Hematopoietic Stem-Cell Transplantation in Older Patients With De Novo Myelodysplastic Syndromes: An International Collaborative Decision Analysis",
      "journal": "Journal of Clinical Oncology",
      "year": 2013,
      "citationCount": 281,
      "doi": "10.1200/jco.2012.46.8652",
      "sourceUrl": "https://doi.org/10.1200/jco.2012.46.8652",
      "verified": true
    },
    {
      "title": "Impact of the degree of anemia on the outcome of patients with myelodysplastic syndrome and its integration into the WHO classification-based Prognostic Scoring System (WPSS)",
      "journal": "Haematologica",
      "year": 2011,
      "citationCount": 280,
      "doi": "10.3324/haematol.2011.044602",
      "sourceUrl": "https://doi.org/10.3324/haematol.2011.044602",
      "verified": true
    },
    {
      "title": "Frequent mutation of the polycomb-associated gene ASXL1 in the myelodysplastic syndromes and in acute myeloid leukemia",
      "journal": "Leukemia",
      "year": 2010,
      "citationCount": 259,
      "doi": "10.1038/leu.2010.20",
      "sourceUrl": "https://doi.org/10.1038/leu.2010.20",
      "verified": true
    },
    {
      "title": "Prediction of Risk for Myeloid Malignancy in Clonal Hematopoiesis",
      "journal": "NEJM Evidence",
      "year": 2023,
      "citationCount": 258,
      "doi": "10.1056/evidoa2200310",
      "sourceUrl": "https://doi.org/10.1056/evidoa2200310",
      "verified": true
    },
    {
      "title": "Relation between JAK2 (V617F) mutation status, granulocyte activation, and constitutive mobilization of CD34+ cells into peripheral blood in myeloproliferative disorders",
      "journal": "Blood",
      "year": 2005,
      "citationCount": 254,
      "doi": "10.1182/blood-2005-09-3826",
      "sourceUrl": "https://doi.org/10.1182/blood-2005-09-3826",
      "verified": true
    },
    {
      "title": "TP53 mutation status divides myelodysplastic syndromes with complex karyotypes into distinct prognostic subgroups",
      "journal": "Leukemia",
      "year": 2019,
      "citationCount": 250,
      "doi": "10.1038/s41375-018-0351-2",
      "sourceUrl": "https://doi.org/10.1038/s41375-018-0351-2",
      "verified": true
    },
    {
      "title": "Clinical Relevance of Bone Marrow Fibrosis and CD34-Positive Cell Clusters in Primary Myelodysplastic Syndromes",
      "journal": "Journal of Clinical Oncology",
      "year": 2008,
      "citationCount": 248,
      "doi": "10.1200/jco.2008.18.2246",
      "sourceUrl": "https://doi.org/10.1200/jco.2008.18.2246",
      "verified": true
    },
    {
      "title": "Combining gene mutation with gene expression data improves outcome prediction in myelodysplastic syndromes",
      "journal": "Nature Communications",
      "year": 2015,
      "citationCount": 248,
      "doi": "10.1038/ncomms6901",
      "sourceUrl": "https://doi.org/10.1038/ncomms6901",
      "verified": true
    },
    {
      "title": "Driver somatic mutations identify distinct disease entities within myeloid neoplasms with myelodysplasia",
      "journal": "Blood",
      "year": 2014,
      "citationCount": 243,
      "doi": "10.1182/blood-2014-03-560227",
      "sourceUrl": "https://doi.org/10.1182/blood-2014-03-560227",
      "verified": true
    },
    {
      "title": "Standardization of flow cytometry in myelodysplastic syndromes: a report from an international consortium and the European LeukemiaNet Working Group",
      "journal": "Leukemia",
      "year": 2012,
      "citationCount": 243,
      "doi": "10.1038/leu.2012.30",
      "sourceUrl": "https://doi.org/10.1038/leu.2012.30",
      "verified": true
    },
    {
      "title": "Risk stratification based on both disease status and extra-hematologic comorbidities in patients with myelodysplastic syndrome",
      "journal": "Haematologica",
      "year": 2010,
      "citationCount": 241,
      "doi": "10.3324/haematol.2010.033506",
      "sourceUrl": "https://doi.org/10.3324/haematol.2010.033506",
      "verified": true
    },
    {
      "title": "Standardization of flow cytometry in myelodysplastic syndromes: report from the first European LeukemiaNet working conference on flow cytometry in myelodysplastic syndromes",
      "journal": "Haematologica",
      "year": 2009,
      "citationCount": 236,
      "doi": "10.3324/haematol.2009.005801",
      "sourceUrl": "https://doi.org/10.3324/haematol.2009.005801",
      "verified": true
    },
    {
      "title": "Impact of spliceosome mutations on RNA splicing in myelodysplasia: dysregulated genes/pathways and clinical associations",
      "journal": "Blood",
      "year": 2018,
      "citationCount": 232,
      "doi": "10.1182/blood-2018-04-843771",
      "sourceUrl": "https://doi.org/10.1182/blood-2018-04-843771",
      "verified": true
    },
    {
      "title": "Disruption of SF3B1 results in deregulated expression and splicing of key genes and pathways in myelodysplastic syndrome hematopoietic stem and progenitor cells",
      "journal": "Leukemia",
      "year": 2014,
      "citationCount": 198,
      "doi": "10.1038/leu.2014.331",
      "sourceUrl": "https://doi.org/10.1038/leu.2014.331",
      "verified": true
    },
    {
      "title": "WHO classification and WPSS predict posttransplantation outcome in patients with myelodysplastic syndrome: a study from the Gruppo Italiano Trapianto di Midollo Osseo (GITMO)",
      "journal": "Blood",
      "year": 2008,
      "citationCount": 194,
      "doi": "10.1182/blood-2008-03-143735",
      "sourceUrl": "https://doi.org/10.1182/blood-2008-03-143735",
      "verified": true
    },
    {
      "title": "Genomic profiling for clinical decision making in myeloid neoplasms and acute leukemia",
      "journal": "Blood",
      "year": 2022,
      "citationCount": 193,
      "doi": "10.1182/blood.2022015853",
      "sourceUrl": "https://doi.org/10.1182/blood.2022015853",
      "verified": true
    },
    {
      "title": "An international consortium proposal of uniform response criteria for myelodysplastic/myeloproliferative neoplasms (MDS/MPN) in adults",
      "journal": "Blood",
      "year": 2015,
      "citationCount": 190,
      "doi": "10.1182/blood-2014-10-607341",
      "sourceUrl": "https://doi.org/10.1182/blood-2014-10-607341",
      "verified": true
    },
    {
      "title": "Proposed minimal diagnostic criteria for myelodysplastic syndromes (MDS) and potential pre-MDS conditions",
      "journal": "Oncotarget",
      "year": 2017,
      "citationCount": 185,
      "doi": "10.18632/oncotarget.19008",
      "sourceUrl": "https://doi.org/10.18632/oncotarget.19008",
      "verified": true
    },
    {
      "title": "Aberrant splicing and defective mRNA production induced by somatic spliceosome mutations in myelodysplasia",
      "journal": "Nature Communications",
      "year": 2018,
      "citationCount": 181,
      "doi": "10.1038/s41467-018-06063-x",
      "sourceUrl": "https://doi.org/10.1038/s41467-018-06063-x",
      "verified": true
    },
    {
      "title": "Predictive factors for the outcome of allogeneic transplantation in patients with MDS stratified according to the revised IPSS-R",
      "journal": "Blood",
      "year": 2014,
      "citationCount": 175,
      "doi": "10.1182/blood-2013-12-542720",
      "sourceUrl": "https://doi.org/10.1182/blood-2013-12-542720",
      "verified": true
    },
    {
      "title": "Time-dependent changes in mortality and transformation risk in MDS",
      "journal": "Blood",
      "year": 2016,
      "citationCount": 174,
      "doi": "10.1182/blood-2016-02-700054",
      "sourceUrl": "https://doi.org/10.1182/blood-2016-02-700054",
      "verified": true
    },
    {
      "title": "Proposals for revised IWG 2018 hematological response criteria in patients with MDS included in clinical trials",
      "journal": "Blood",
      "year": 2018,
      "citationCount": 170,
      "doi": "10.1182/blood-2018-06-857102",
      "sourceUrl": "https://doi.org/10.1182/blood-2018-06-857102",
      "verified": true
    },
    {
      "title": "Multicenter validation of a reproducible flow cytometric score for the diagnosis of low-grade myelodysplastic syndromes: results of a European LeukemiaNET study",
      "journal": "Haematologica",
      "year": 2012,
      "citationCount": 165,
      "doi": "10.3324/haematol.2011.048421",
      "sourceUrl": "https://doi.org/10.3324/haematol.2011.048421",
      "verified": true
    },
    {
      "title": "Diagnostic utility of flow cytometry in low-grade myelodysplastic syndromes: a prospective validation study",
      "journal": "Haematologica",
      "year": 2009,
      "citationCount": 165,
      "doi": "10.3324/haematol.2009.008532",
      "sourceUrl": "https://doi.org/10.3324/haematol.2009.008532",
      "verified": true
    },
    {
      "title": "Predicting survival and leukemic evolution in patients with myelodysplastic syndrome.",
      "journal": "PubMed",
      "year": 2006,
      "citationCount": 163,
      "doi": null,
      "sourceUrl": "https://openalex.org/W2147424262",
      "verified": true
    },
    {
      "title": "Prognostic impact of pre-transplantation transfusion history and secondary iron overload in patients with myelodysplastic syndrome undergoing allogeneic stem cell transplantation: a GITMO study",
      "journal": "Haematologica",
      "year": 2009,
      "citationCount": 161,
      "doi": "10.3324/haematol.2009.011429",
      "sourceUrl": "https://doi.org/10.3324/haematol.2009.011429",
      "verified": true
    },
    {
      "title": "Gene expression profiling of CD34<sup>+</sup> cells in patients with the 5q− syndrome",
      "journal": "British Journal of Haematology",
      "year": 2007,
      "citationCount": 153,
      "doi": "10.1111/j.1365-2141.2007.06833.x",
      "sourceUrl": "https://doi.org/10.1111/j.1365-2141.2007.06833.x",
      "verified": true
    },
    {
      "title": "ClinGen Myeloid Malignancy Variant Curation Expert Panel recommendations for germline RUNX1 variants",
      "journal": "Blood Advances",
      "year": 2019,
      "citationCount": 150,
      "doi": "10.1182/bloodadvances.2019000644",
      "sourceUrl": "https://doi.org/10.1182/bloodadvances.2019000644",
      "verified": true
    }
  ],
  "awards": [],
  "timeline": [],
  "mentors": [],
  "students": [],
  "lastFixedAt": "2026-02-16T05:45:21.000Z",
  "openalexId": "https://openalex.org/A5072513476"
}